Hall Private Wealth Advisors Nektar Therapeutics Transaction History
Hall Private Wealth Advisors
- $149 Million
- Q3 2023
A detailed history of Hall Private Wealth Advisors transactions in Nektar Therapeutics stock. As of the latest transaction made, Hall Private Wealth Advisors holds 10,000 shares of NKTR stock, worth $236,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$236,000% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NKTR
# of Institutions
22Shares Held
16.1MCall Options Held
17.2KPut Options Held
0-
Black Rock Inc. New York, NY15.2MShares$358 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY491KShares$11.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$7.71 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$1.22 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ18.6KShares$438,1810.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $4.42B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...